Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Calais

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|March 30, 2004
[Docetaxel and squamous cell carcinoma of the head and neck]Gilles Calais
The Oncologist|November 2, 2010
TPF: a rational choice for larynx preservation?Gilles Calais
La Revue Du Praticien|December 2, 2006
[Non surgical treatment approach for head and neck cancer]Yoann Pointreau, Gilles Calais
Therapeutic Drug Monitoring|September 16, 2016
Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck CancerYoann Pointreau, Nicolas Azzopardi, David Ternant, et al.
Anti-Cancer Drugs|December 17, 2010
Induction chemotherapy in head and neck cancer: a new paradigmYoann Pointreau, Ibrahim Atean, Jérôme Fayette, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2024
[Short- and medium-term tolerance of hypofractionated prostate radiotherapy with simultaneous integrated boost]Laurène Larrivière, Stephane Supiot, Astrid Thomin, et al.
Pharmacy World & Science : PWS|April 17, 2004
A prescription and administration error of cisplatin: a case reportXavier Pourrat, Daniel Antier, Isabelle Crenn, et al.
Current Opinion in Oncology|April 8, 2004
Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitationsJean Bourhis, Atoussa Etessami, Pierre Wilbault, et al.
Frontiers in Oncology|January 24, 2022
Mapping of Recurrence Sites Following Adjuvant or Salvage Radiotherapy for Prostate Cancer PatientsAna Gonzalez-Moya, Stéphane Supiot, Valérie Seegers, et al.
Psycho-Oncology|February 9, 2012
Depression is associated with some patient-perceived cosmetic changes, but not with radiotherapy-induced late toxicity, in long-term breast cancer survivorsPaul Brunault, Isabelle Suzanne, Magdalena Trzepidur-Edom, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|March 30, 2004
[Docetaxel and squamous cell carcinoma of the head and neck]Gilles Calais
The Oncologist|November 2, 2010
TPF: a rational choice for larynx preservation?Gilles Calais
La Revue Du Praticien|December 2, 2006
[Non surgical treatment approach for head and neck cancer]Yoann Pointreau, Gilles Calais
Therapeutic Drug Monitoring|September 16, 2016
Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck CancerYoann Pointreau, Nicolas Azzopardi, David Ternant, et al.
Anti-Cancer Drugs|December 17, 2010
Induction chemotherapy in head and neck cancer: a new paradigmYoann Pointreau, Ibrahim Atean, Jérôme Fayette, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2024
[Short- and medium-term tolerance of hypofractionated prostate radiotherapy with simultaneous integrated boost]Laurène Larrivière, Stephane Supiot, Astrid Thomin, et al.
Pharmacy World & Science : PWS|April 17, 2004
A prescription and administration error of cisplatin: a case reportXavier Pourrat, Daniel Antier, Isabelle Crenn, et al.
Current Opinion in Oncology|April 8, 2004
Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitationsJean Bourhis, Atoussa Etessami, Pierre Wilbault, et al.
Frontiers in Oncology|January 24, 2022
Mapping of Recurrence Sites Following Adjuvant or Salvage Radiotherapy for Prostate Cancer PatientsAna Gonzalez-Moya, Stéphane Supiot, Valérie Seegers, et al.
Psycho-Oncology|February 9, 2012
Depression is associated with some patient-perceived cosmetic changes, but not with radiotherapy-induced late toxicity, in long-term breast cancer survivorsPaul Brunault, Isabelle Suzanne, Magdalena Trzepidur-Edom, et al.
Pageof 6